Abstract Recombinant LL‐37 Lactococcus lactis (Oral LL‐37) was designed to prevent
progression of COVID‐19 by targeting virus envelope, however, effectiveness and safety of …

Probiotics and related preparations, including synbiotics and postbiotics, are living and non-
living microbial-based multi-components, which are now among the most popular bioactive …

Las infecciones del tracto respiratorio suelen ser causadas por virus o bacterias. En esta
parte conviven una gran cantidad de microorganismos potencialmente patógenos junto con …

Background A number of laboratory data and clinical studies have shown that probiotic
bacteria may be beneficial in respiratory viral diseases. We investigated the role of …

Background. An increasing number of studies have proved that gut microbiota is involved in
the occurrence and development of various lung diseases and can interact with the …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) recently caused a global
pandemic, resulting in more than 702 million people being infected and over 6.9 million …

Abstract Background Viral respiratory infections (VRIs) continue to be among the most
common illnesses and are known to be one of the main reasons of medical consultations …

A severe consequence of SARS-CoV-2 infection that manifests as systemic inflammation
and multi-organ involvement is called Multisystem Inflammatory Syndrome in Children (MIS …

The 10th International Yakult Symposium was held in Milan, Italy, on 13–14 October 2022.
Two keynote lectures covered the crewed journey to space and its implications for the …

COVID-19, which is caused by the RNA virus, SARS-CoV-2, mainly affects the respiratory
system and has a varied clinical presentation. However, several studies have shown that …